UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 5/2009, Volume 48, Issue 10, pp. 1441 - 1458
Antifungals | Enzymes | Azoles | Volunteerism | Drug interactions | Cytochromes | Reviews of Anti-Infective Agents | Bioavailability | Pharmacokinetics | Dosage | Metabolism | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - pharmacology | Azoles - pharmacokinetics | Drug Interactions | Azoles - pharmacology | Antifungal Agents - pharmacokinetics | Humans | Physiological aspects | Dosage and administration | Research | Prescription drugs | Pharmacology | Fungal infections | Medical treatment | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2018, Volume 319, Issue 7, pp. 680 - 690
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Intensive Care Units | Double-Blind Method | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Haloperidol - administration & dosage | Male | Haloperidol - adverse effects | Antipsychotic Agents - administration & dosage | Dose-Response Relationship, Drug | Critical Illness - mortality | Delirium - prevention & control | Survival Analysis | Adult | Female | Aged | Delirium | Treatment outcome | Safety and security measures | Critically ill | Analysis | Dosage and administration | Diagnosis | Haloperidol | Health aspects | Risk factors | Coma | Mental disorders | Clinical trials | Risk | Sodium chloride | Patients | Survival | Impact analysis | Incidence | Studies | Sodium | Ventilation | Adults | Index Medicus | Abridged Index Medicus | Caring for the Critically Ill Patient | Original Investigation | Research
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2013, Volume 68, Issue 2, pp. 385 - 393
Additivity | Echinocandins | Azoles | Synergy | Combination therapy | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Triazoles - administration & dosage | Pyrimidines - administration & dosage | Echinocandins - pharmacokinetics | Treatment Outcome | Pyrimidines - pharmacology | Drug Synergism | Echinocandins - administration & dosage | Triazoles - pharmacology | Drug Therapy, Combination - methods | Animals | Antifungal Agents - pharmacokinetics | Survival Analysis | Voriconazole | Pyrimidines - pharmacokinetics | Female | Triazoles - pharmacokinetics | Mice | Antifungal Agents - administration & dosage | Drug Resistance, Fungal | Echinocandins - pharmacology | Aspergillosis - drug therapy | Disease Models, Animal | Pharmacology | Fungal infections | Drug resistance | Drug therapy | Laboratory animals | Index Medicus | Infection | Animal models | Pharmacodynamics | azoles | Body weight | Aspergillosis | Clinical isolates | Drug interaction | Regression analysis | Survival
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2013, Volume 57, Issue 4, pp. 1888 - 1894
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Models, Theoretical | Pyrimidines - therapeutic use | Humans | Voriconazole | Hematopoietic Stem Cell Transplantation | Adult | Software | Immunocompromised Host - drug effects | Triazoles - therapeutic use | Index Medicus | Bayesian analysis | Pharmacology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2010, Volume 54, Issue 2, pp. 860 - 865
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Triazoles - administration & dosage | Drug Administration Schedule | Administration, Oral | Area Under Curve | Fungal Proteins - genetics | Aspergillus fumigatus - genetics | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Triazoles - pharmacology | Animals | Antifungal Agents - pharmacokinetics | Aspergillosis - microbiology | Aspergillus fumigatus - physiology | Cytochrome P-450 Enzyme System - genetics | Female | Triazoles - pharmacokinetics | Mice | Mutation | Antifungal Agents - administration & dosage | Aspergillosis - drug therapy | Disease Models, Animal | Triazoles - therapeutic use | Index Medicus | Susceptibility
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 4/2018, Volume 57, Issue 4, pp. 475 - 489
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Body Weight | Age Factors | Humans | Immunosuppressive Agents - pharmacokinetics | Child, Preschool | Male | Drug Dosage Calculations | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Computer Simulation | Pharmacogenomic Variants | Female | Retrospective Studies | Child | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Drug Administration Schedule | Tacrolimus - blood | Graft Rejection - prevention & control | Genotype | Treatment Outcome | Tacrolimus - pharmacokinetics | Tacrolimus - adverse effects | Cytochrome P-450 CYP3A - metabolism | Models, Biological | Adolescent | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Tissue Donors | Graft Survival - drug effects | Nonlinear Dynamics | Kidney Transplantation - adverse effects
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2008, Volume 47, Issue 10, pp. 1270 - 1276
Highly active antiretroviral therapy | Candidiasis | Relapse | Azoles | HIV | Mycology | Articles and Commentaries | AIDS | Dosage | Lesions | Symptoms | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Oropharynx - microbiology | Antifungal Agents - adverse effects | Prospective Studies | Double-Blind Method | Humans | Middle Aged | Fluconazole - administration & dosage | Fluconazole - adverse effects | Male | Treatment Outcome | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | HIV Infections - complications | Candidiasis, Oral - drug therapy | Adult | Female | Aged | Antifungal Agents - administration & dosage | Placebos - administration & dosage | Dosage and administration | Research | Fluconazole | Drug therapy | Patient outcomes | Thrush (Mouth disease) | Clinical trials | Antiretroviral drugs | Fungal infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 05/2020, Volume 80, Issue 7, pp. 671 - 695
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Animals | Injections, Intravenous | Administration, Oral | Antifungal Agents - pharmacokinetics | Humans | Drug Compounding | Triazoles - pharmacokinetics | Antifungal Agents - administration & dosage | Aspergillosis - drug therapy | Pathogens | Yeasts | Enzymes | Pharmacodynamics | Intravenous administration | Toxicity | Medical treatment | Prophylaxis | Infections | Pharmacology | Exposure | Small intestine | Patients | Absorption | Fungal diseases | Aspergillosis | Immunocompromised hosts | Mutation | Pharmacokinetics | Posaconazole | Drug dosages
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 2015, Volume 59, Issue 5, pp. 2855 - 2866
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Triazoles - blood | Pyridines - pharmacokinetics | Aspergillus fumigatus - pathogenicity | Nitriles - pharmacokinetics | Pyridines - blood | Animals | Nitriles - blood | Aspergillosis - metabolism | Female | Triazoles - pharmacokinetics | Mice | Aspergillosis - blood | Aspergillosis - drug therapy | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Index Medicus | Pharmacology
Journal Article